25 May 2013
Keywords: gsk, vertex, unveil, new, data, hiv, prodrug
Article | 17 February 2003
GlaxoSmithKline and Vertex Pharmaceuticals have reported encouraging48-week data from the NEAT and SOLO studies of their new HIV protease
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 February 2003
24 May 2013
© 2013 thepharmaletter.com